for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

REFILE-FACTBOX-Vaccines delivered under COVAX vaccine-sharing scheme

 (Refiles March 26 story to fix headline and date)
    March 26 (Reuters) - The COVAX facility, backed by the World Health Organization (WHO) and
the Global Alliance for Vaccines and Immunization (GAVI), aims to secure 2 billion vaccine doses
for lower income countries by the end of 2021.
    In early March, it said the target was to deliver 237 million doses of AstraZeneca's
shot to 142 countries by the end of May, and it also shipped its first Pfizer shots.

    The following tables list the countries that have received vaccines under the scheme, sorted
by region and delivery date:

    AFRICA & MIDDLE EAST
 COUNTRY            LATEST        DATE         VACCINE TYPE        POPULATION    TOTAL
                    DELIVERY                                                     DELIVERED
 Ghana              600,000       Feb. 24      AstraZeneca/Oxford  30 million    600,000
 Ivory Coast        504,000       Feb. 26      AstraZeneca/Oxford  26 million    504,000
 Nigeria            3.9 million   March 2      AstraZeneca/Oxford  201 million   3.9 million
 Democratic         1.7 million   March 2      AstraZeneca/Oxford  87 million    1.7 million
 Republic of Congo                                                               
 Angola             624,000       March 2      AstraZeneca/Oxford  32 million    624,000
 Gambia             36,000        March 2      AstraZeneca/Oxford  2.3 million   36,000
 Senegal            324,000       March 3      AstraZeneca/Oxford  16 million    324,000
 Kenya              1 million     March 3      AstraZeneca/Oxford  53 million    1 million
 Rwanda             240,000       March 3      AstraZeneca/Oxford  13 million    342,920
                    102,960                    Pfizer BioNTech                   
 Sudan              828,000       March 3      AstraZeneca/Oxford  43 million    828,000
 Sao Tome and       24,000        March 3      AstraZeneca/Oxford  215,000       24,000
 Principe                                                                        
 Lesotho            36,000        March 3      AstraZeneca/Oxford  2.1 million   36,000
 Mali               396,000       March 4      AstraZeneca/Oxford  20 million    396,000
 Uganda             864,000       March 5      AstraZeneca/Oxford  44 million    864,000
 Malawi             360,000       March 5      AstraZeneca/Oxford  19 million    360,000
 Liberia            96,000        March 5      AstraZeneca/Oxford  4.9 million   96,000
 Djibouti           24,000        March 6      AstraZeneca/Oxford  990,000       24,000
 Ethiopia           2.2 million   March 7      AstraZeneca/Oxford  112 million   2.2 million
 Togo               156,000       March 8      AstraZeneca/Oxford  8.1 million   156,000
 Mozambique         384,000       March 8      AstraZeneca/Oxford  30 million    384,000
 Sierra Leone       96,000        March 8      AstraZeneca/Oxford  7.8 million   96,000
 Benin              144,000       March 10     AstraZeneca/Oxford  12 million    144,000
 Cabo Verde         24,000        March 12     AstraZeneca/Oxford  540,000       24,000
 Jordan             144,000       March 12     AstraZeneca/Oxford  10 million    144,000
 Eswatini           12,000        March 13     AstraZeneca/Oxford  1.1 million   12,000
 Somalia            300,000       March 15     AstraZeneca/Oxford  15 million    300,000
 Palestinian        24,000        March 17     AstraZeneca/Oxford  4.7 million   61,440
 Territories        37,440                     Pfizer BioNTech                   
 Tunisia            93,600        March 17     Pfizer BioNTech     12 million    93,600
 Lebanon            33,600        March 24     AstraZeneca/Oxford  6.9 million   33,600
 South Sudan        132,000       March 25     AstraZeneca/Oxford  11 million    132,000
 Iraq               336,000       March 25     AstraZeneca/Oxford  39.3 million  336,000
 
    EUROPE
 COUNTRY      LATEST        DATE        VACCINE TYPE            POPULATION     TOTAL
              DELIVERY                                                         DELIVERED
 Moldova      14,400        March 4     N/A                     2.7 million    14,400
 Albania      38,400        March 12    AstraZeneca/Oxford      2.9 million    38,400
 Georgia      43,200        March 13    AstraZeneca/Oxford      3.7 million    43,200
 Bosnia       23,400        March 25    Pfizer BioNTech         3.3 million    49,800
              26,400                    AstraZeneca/Oxford                     
 
    ASIA & PACIFIC
 COUNTRY      LATEST       DATE        VACCINE TYPE            POPULATION      TOTAL
              DELIVERY                                                         DELIVERED
 Cambodia     324,000      March 2     AstraZeneca/Oxford      16 million      324,000
 Philippines  487,200      March 4     AstraZeneca/Oxford      108 million     487,200
 Fiji         12,000       March 6     AstraZeneca/Oxford      900,000         12,000
 Nepal        348,000      March 7     AstraZeneca/Oxford      29 million      348,000
 Maldives     12,000       March 7     AstraZeneca/Oxford      531,000         12,000
 Sri Lanka    264,000      March 7     AstraZeneca/Oxford      22 million      264,000
 Indonesia    1.1 million  March 8     AstraZeneca/Oxford      271 million     1.1 million
 Afghanistan  468,000      March 8     AstraZeneca/Oxford      38 million      468,000
 Tajikistan   192,000      March 9     AstraZeneca/Oxford      9.3 million     192,000
                                                                               
 Uzbekistan   660,000      March 17    AstraZeneca/Oxford      34 million      660,000
 Solomon      24,000       March 19    AstraZeneca/Oxford      670,000         24,000
 Islands                                                                       
 Laos         132,000      March 20    AstraZeneca/Oxford      7.2 million     132,000
 Mongolia     25,700       March 25    AstraZeneca/Oxford      3.2 million     40,100
                                       Pfizer BioNTech                         
 
    AMERICAS
 COUNTRY      LATEST      DATE         VACCINE TYPE            POPULATION       TOTAL
              DELIVERY                                                          DELIVERED
 Peru         117,000     March 10     Pfizer/BioNTech         33 million       117,000
 Guatemala    81,600      March 11     AstraZeneca/Oxford      17 million       81,600
                                                                                
 Honduras     48,000      March 13     AstraZeneca/Oxford      9.7 million      48,000
 Jamaica      14,400      March 15     AstraZeneca/Oxford      2.9 million      14,400
 Nicaragua    135,000     March 16     AstraZeneca/Oxford      6.5 million      135,000
 Ecuador      84,000      March 17     AstraZeneca/Oxford      17 million       84,000
 Paraguay     36,000      March 19     AstraZeneca/Oxford      7.0 million      36,000
 Colombia     244,800     March 20     AstraZeneca/Oxford      50 million       361,800
 Brazil       1 million   March 21     AstraZeneca/Oxford      214 million      1 million
 Bolivia      228,000     March 21     AstraZeneca/Oxford      12 million       228,000
 El Salvador  51,480      March 22     Pfizer/BioNTech         6.5 million      85,000
 
    Sources: Reuters news reports, WHO, UNICEF, GAVI

    
 (Reporting by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki and Antonis Triantafyllou in
Gdansk; Editing by Milla Nissi and Tomasz Janowski)
  
for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up